000 | 03149nam a22006255i 4500 | ||
---|---|---|---|
001 | 978-3-319-09665-0 | ||
003 | DE-He213 | ||
005 | 20250526092115.0 | ||
007 | cr nn 008mamaa | ||
008 | 141218s2015 sz | s |||| 0|eng d | ||
020 |
_a9783319096650 _9978-3-319-09665-0 |
||
024 | 7 |
_a10.1007/978-3-319-09665-0 _2doi |
|
050 | 4 | _aRM300-666 | |
072 | 7 |
_aMMG _2bicssc |
|
072 | 7 |
_aMED071000 _2bisacsh |
|
072 | 7 |
_aMKG _2thema |
|
082 | 0 | 4 |
_a615 _223 |
245 | 1 | 0 |
_aHigh Density Lipoproteins _h[electronic resource] : _bFrom Biological Understanding to Clinical Exploitation / _cedited by Arnold von Eckardstein, Dimitris Kardassis. |
250 | _a1st ed. 2015. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2015. |
|
300 |
_aXIII, 694 p. 40 illus., 37 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aHandbook of Experimental Pharmacology, _x1865-0325 ; _v224 |
|
505 | 0 | _aPreface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL. | |
506 | 0 | _aOpen Access | |
520 | _aIn this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases. | ||
650 | 0 | _aPharmacology. | |
650 | 0 |
_aMedicine _xResearch. |
|
650 | 0 |
_aBiology _xResearch. |
|
650 | 0 | _aHuman physiology. | |
650 | 0 | _aImmunology. | |
650 | 0 | _aCytology. | |
650 | 1 | 4 | _aPharmacology. |
650 | 2 | 4 | _aBiomedical Research. |
650 | 2 | 4 | _aHuman Physiology. |
650 | 2 | 4 | _aImmunology. |
650 | 2 | 4 | _aCell Biology. |
700 | 1 |
_avon Eckardstein, Arnold. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aKardassis, Dimitris. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783319096643 |
776 | 0 | 8 |
_iPrinted edition: _z9783319096667 |
776 | 0 | 8 |
_iPrinted edition: _z9783319348612 |
830 | 0 |
_aHandbook of Experimental Pharmacology, _x1865-0325 ; _v224 |
|
856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-319-09665-0 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
912 | _aZDB-2-SOB | ||
999 |
_c6 _d6 |